Malte Greune
Chief Operating Officer presso CUREVAC N.V.
Patrimonio netto: 6 299 $ in data 31/03/2024
Profilo
Malte Greune occupa la posizione di Chief Operating & Production Officer presso CureVac NV. In passato ha ricoperto la posizione di VP-Cartucce, Dispositivi & Gruppo Tecnologico Insulina presso Sanofi-Aventis Deutschland GmbH. Ha ricevuto un dottorato dalla Universitt zu Kln, una laurea presso l'Universität Trier e un MBA presso la Clark University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
CUREVAC N.V.
0.00% | 31/03/2023 | 2 079 ( 0.00% ) | 6 299 $ | 31/03/2024 |
Posizioni attive di Malte Greune
Società | Posizione | Inizio |
---|---|---|
CUREVAC N.V. | Chief Operating Officer | 01/07/2021 |
Precedenti posizioni note di Malte Greune
Società | Posizione | Fine |
---|---|---|
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Corporate Officer/Principal | - |
Formazione di Malte Greune
Clark University | Masters Business Admin |
Universität zu Köln | Doctorate Degree |
University of Trier | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
CUREVAC N.V. | Health Technology |
Aziende private | 1 |
---|---|
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Health Technology |
- Borsa valori
- Insiders
- Malte Greune